Nuclear Antigen antibody
-
- Target See all Nuclear Antigen (IPO-38) Antibodies
- Nuclear Antigen (IPO-38)
- Reactivity
- Human, Mouse, Rat
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- This Nuclear Antigen antibody is un-conjugated
-
Application
- Flow Cytometry (FACS), Immunofluorescence (IF), Immunohistochemistry (IHC)
- Purpose
- Mouse anti-Human/Mouse/Rat IPO-38 Antibody (Proliferation Marker) [Sodium Azide Free]
- Specificity
- Nuclear
- Purification
- Spleen cells from a patient with hairy cell leukemia were used as the immunogen for the IPO-38 antibody.
- Immunogen
- Spleen cells from a patient with hairy cell leukemia were used as the immunogen for the IPO-38 antibody.
- Top Product
- Discover our top product IPO-38 Primary Antibody
-
-
- Application Notes
-
Flow Cytometry: 0.5-1 μg/million cells in 0.1ml
Immunofluorescence: 0.5-1 μg/mL
Immunohistochemistry (FFPE): 0.5-1 μg/mL for 30 min at RT (1)
Prediluted format: incubate for 30 min at RT (2) - Restrictions
- For Research Use only
-
- Buffer
- In 1X PBS, BSA free, sodium azide free
- Preservative
- Azide free
- Storage
- 4 °C,-20 °C
- Storage Comment
- 2-8°C. The azide-free format should be aliquoted and stored at -20°C or colder.
-
- Target
- Nuclear Antigen (IPO-38)
- Alternative Name
- IPO38 (IPO-38 Products)
- Background
-
Target Description: Recognizes a protein of 14-16 kDa, which is a novel nuclear antigen of proliferating cells. IPO38 antigen is present in the nuclei of proliferating cells such as Hodgkin s disease and non-Hodgkin s lymphomas, different forms of leukemias, breast and colorectal carcinomas, and PHA-stimulated lymphocytes. It is not expressed in the cells of non-stimulated lymphocytes and granulocytes. IPO38 may be a useful marker of cell proliferation during monitoring of tumor progression.
-